Scope new network opportunities based on market demand and partner needs, Validate concepts with prospective partners through structured discussions and early design collaboration, Play an active role in business development by identifying potential partners, having introductory conversations, and securing commitments, Set up new networks, including defining initial scope, timelines, and partner contributions, Own execution across one or more Apheris networks, working directly with leading pharma partners to turn their data into shared, high-performance models, Drive federated network management end-to-end, from partner data onboarding and harmonization to model aggregation and delivery of weights and inference containers in collaboration with Apheris’ technical and domain experts, Maintain and push forward a clear execution plan across partners, spanning data readiness, training runs, and benchmarking milestones, Define how Apheris networks evolve, including adding new endpoints, expanding to new modalities, and increasing the value delivered to partners over time, Work with BD and product to launch new network tracks and bring additional pharma partners into the network, Turn emerging opportunities into scoped initiatives, proposals, and execution plans, Act as the day-to-day counterpart to partner teams, working closely with senior scientists and leaders at top pharma companies, Lead working sessions on model performance, benchmarking results, and deployment approaches together with Apheris’ domain experts, shaping how federated models are used in practice, Drive discussions toward clear decisions, whether on evaluation criteria, rollout strategies, or next areas of investment, Build trusted relationships with partners while pushing conversations forward and maintaining a high bar for progress, Identify where to push, expand scope, or activate additional stakeholders, Bring federated models into real-world usage by driving deployment into partner environments and integration into existing workflows, Help partners move from evaluating models to using them in active drug discovery programs, Track how models are used across the network and identify opportunities to expand impact across teams and programs, Continuously improve how Apheris models are delivered and consumed in collaboration with Product, making it faster and easier for partners to realize value
